Epidermal growth factor-dependent dissociation of CrkII proto-oncogene product from the epidermal growth factor receptor in human glioma cells

Japanese Journal of Cancer Research

Volumn 90, Issue 10, 1999, Pages 1096-1103

  Katayama, Haruko ^a   Hashimoto, Yuko ^a   Kiyokawa, Etsuko ^a   Nakaya, Mie ^b   Sakamoto, Atsuhiko ^c   Machinami, Rikuo ^c   Kurata, Takeshi ^a   Mochizuki, Naoki ^b   Matsuda, Michiyuki ^b  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Adaptor protein; Crk; Epidermal growth factor; Glioma; Tyrosine kinase

Indexed keywords

ADAPTOR PROTEIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; TYROSINE;

ARTICLE; CARCINOGENICITY; DISSOCIATION; GLIOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; SUPPRESSOR GENE;

EID: 0032745159     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00683.x     Document Type: Article

References (27)

1. Arita, N., Hayakawa, T., Izumoto, S., Taki, T., Ohnishi, T., Yamamoto, H., Bitoh, S. and Mogami, H. Epidermal growth factor receptor in human glioma. J. Neurosurg., 70, 916-919 (1989).
2. Diedrich, U., Lucius, J., Baron, E., Behnke, J., Pabst, B. and Zoll, B. Distribution of epidermal growth factor receptor gene amplification in brain tumours and correlation to prognosis. J. Neurol, 242, 683-688 (1995).
3. Nishikawa, R., Ji, X. D., Harmon, R. C., Lazar, C. S., Gill, G. N., Cavenee, W. K. and Huang, H. J. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc. Natl. Acad. Sci. USA, 91, 7727-7731 (1994).
4. Tang, P., Steck, P. A. and Yung, W. K. The autocrine loop of TGF-alpha/EGFR and brain tumors. J. Neurooncol., 35, 303-314 (1997).
5. Mayer, B. J., Hamaguchi, M. and Hanafusa, H. A novel viral oncogene with structural similarity to phospholipase C. Nature, 332, 272-275 (1988).
6. Kizaka-Kondoh, S., Matsuda, M. and Okayama, H. CrkII signals from epidermal growth factor receptor to Ras. Proc. Natl. Acad. Sci. USA, 93, 12177-12182 (1996).
7. Matsuda, M., Tanaka, S., Nagata, S., Kojima, A., Kurata, T. and Shibuya, M. Two species of human CRK cDNA encode proteins with distinct biological activities. Mol. Cell. Biol, 12, 3482-3489 (1992).
8. Reichman, C. T., Mayer, B. J., Keshau, S. and Hanafusa, H. The product of the cellular crk gene consists primarily of SH2 and SH3 regions. Cell Growth Differ., 3, 451-460 (1992).
9. Kiyokawa, E., Mochizuki, N., Kurata, T. and Matsuda, M. Role of Crk oncogene product in physiologic signaling. Crit. Rev. Oncog., 8, 329-342 (1997).
10. Feller, S. M., Knudsen, B. and Hanafusa, H. Cellular proteins binding to the first src homology 3 (SH3) domain of the proto-oncogene product c-crk indicate crk-specific signaling pathways. Oncogene, 10, 1465-1473 (1995).
11. Tanaka, S., Hattori, S., Kurata, T., Nagashima, K., Fukui, Y., Nakamura, S. and Matsuda, M. Both the SH2 and SH3 domains of human CRK protein are required for neuronal differentiation of PC12 cells. Mol. Cell Biol., 13, 4409-4415 (1993).
12. Tanaka, S., Morishita, T., Hashimoto, Y., Hattori, S., Nakamura, S., Takenawa, T., Matuoka, K., Shibuya, M., Kurata, T., Nagashima, K. and Matsuda, M. C3G, a guanine nucleotide releasing protein, binds to the SH3 domains of CRK and ASH/GRB2. Proc. Natl. Acad. Sci. USA, 91, 3443-3447 (1994).
13. Gotoh, T., Hattori, S., Nakamura, S., Kitayama, H., Noda, M., Takai, Y., Kaibuchi, K., Matsui, H., Hatase, O., Takahashi, H., Kurata, T. and Matsuda, M. Identification of Rap1 as a target for Crk SH3 domain-binding guanine nucleotide-releasing factor, C3G. Mol. Cell. Biol., 15, 6746-6753 (1995).
14. Hasegawa, H., Kiyokawa, E., Tanaka, S., Nagashima, K., Gotoh, N., Shibuya, M., Kurata, T. and Matsuda, M. DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the membrane. Mol. Cell. Biol., 16, 1770-1776 (1996).
15. Ota, S., Kizaka-Kondoh, S., Hashimoto, Y., Nishihara, H., Nagashima, K., Kurata, T., Okayama, H. and Matsuda, M. Constitutive association of EGF receptor with the CrkIII-23 mutant that inhibits transformation of NRK cells by EGF and TGF-β. Cell. Signal., 10, 283-290 (1998).
16. Yamazaki, H., Ohba, Y., Tamaoki, N. and Shibuya, M. A deletion mutation within the ligand binding domain is responsible for activation of epidermal growth factor receptor gene in human brain tumors. Jpn. J. Cancer Res., 81, 773-779 (1990).
17. Matsuda, M., Nagata, S., Tanaka, S., Nagashima, K. and Kurata, T. Structural requirement of the CRK SH2 region for the binding to phosphotyrosine-containing proteins: evidence from reactivity to monoclonal antibodies. J. Biol. Chem., 268, 4441-4446 (1993).
18. Hashimoto, Y., Katayama, H., Kiyokawa, E., Ota, S., Kurata, T., Gotoh, N., Shibata, M., Otsuka, N. and Matsuda, M. Phosphorylation of CrkII adaptor protein at Tyrosine 221 by epidermal growth factor receptor. J. Biol. Chem., 273, 17186-17191 (1998).
19. Fukazawa, H., Mizuno, S. and Uehara, Y. A microplate assay for quantitation of anchorage-independent growth of transformed cells. Anal. Biochem., 228, 83-90 (1995).
20. Hunter, T. and Cooper, J. A. Epidermal growth factor induces rapid tyrosine phosphorylation of proteins in A431 human tumor cells. Cell, 24, 741-752 (1981).
21. Feller, S. M., Knudsen, B. and Hanafusa, H. c-Ab1 kinase regulates the protein binding activity of c-Crk. EMBO J., 13, 2341-2351 (1994).
22. Fukazawa, T., Miyake, S., Band, V. and Band, H. Tyrosine phosphorylation of Cb1 upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins. J. Biol. Chem., 271, 14554-14559 (1996).
23. Khwaja, A., Hallberg, B., Warne, P. H. and Downward, J. Networks of interaction of p120(cb1) and p130(cas) with Crk and Grb2 adaptor proteins. Oncogene, 12, 2491-2498 (1996).
24. Galcheva-Gargova, Z., Konstantinov, K. N., Wu, I. H., Klier, F. G., Barrett, T. and Davis, R. J. Binding of zinc finger protein ZPR1 to the epidermal growth factor receptor. Science, 272, 1797-1802 (1996).
25. Cook, S. J., Rubinfeld, B., Albert, I. and McCormick, F. RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts. EMBO J., 12, 3475-3485 (1993).
26. Okada, S., Matsuda, M., Anafi, M., Pawson, T. and Pessin, J. E. Insulin regulates the dynamic balance between Ras and Rap1 signaling by coordinating the assembly states of the Grb2-SOS and CrkII-C3G complexes. EMBO J., 17, 2554-2565 (1998).
27. Gutmann, D. H., Saporito-Irwin, S., DeClue, J. E., Wienecke, R. and Guha, A. Alterations in the rap1 signaling pathway are common in human gliomas. Oncogene, 15, 1611-1616 (1997).